Haudongchun Co., Ltd. Report issue

Government Phase 2

Organization Overview

First Clinical Trial
2016
NCT03357666
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Haudongchun Co., Ltd.